Pathstone Family Office’s Acumen Pharmaceuticals ABOS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	$1.99M	Buy	478,790 +11,730	+3%	+$48.7K	0.02%	474
2023 Q2	$2.25M	Buy	467,060 +75,000	+19%	+$361K	0.03%	297
2023 Q1	$1.59M	Sell	392,060 -668,600	-63%	-$2.71M	0.03%	332
2022 Q4	$5.73M	Buy	1,060,660 +554,120	+109%	+$2.99M	0.05%	261
2022 Q3	$5.08M	Buy	+506,540	New	+$5.08M	0.05%	231